240 related articles for article (PubMed ID: 11997080)
1. gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin.
Naraki T; Kohno N; Saito H; Fujimoto Y; Ohhira M; Morita T; Kohgo Y
Biochim Biophys Acta; 2002 Apr; 1586(3):287-98. PubMed ID: 11997080
[TBL] [Abstract][Full Text] [Related]
2. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.
Uehara S; Gotoh K; Handa H; Tomita H; Senshuu M
J Gastroenterol Hepatol; 2005 Oct; 20(10):1545-52. PubMed ID: 16174072
[TBL] [Abstract][Full Text] [Related]
3. Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II.
Kinukawa H; Shirakawa T; Yoshimura T
Clin Biochem; 2015 Nov; 48(16-17):1120-5. PubMed ID: 26297114
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification of gamma-carboxyglutamic acid residues in prothrombin elicits a conformation similar to that of abnormal (des-gamma-carboxy)prothrombin.
Sugo T; Watanabe K; Naraki T; Matsuda M
J Biochem; 1990 Sep; 108(3):382-7. PubMed ID: 2277030
[TBL] [Abstract][Full Text] [Related]
5. Des-γ-carboxy prothrombin (DCP) as a potential autologous growth factor for the development of hepatocellular carcinoma.
Zhang YS; Chu JH; Cui SX; Song ZY; Qu XJ
Cell Physiol Biochem; 2014; 34(3):903-15. PubMed ID: 25200250
[TBL] [Abstract][Full Text] [Related]
6. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma.
Nagaoka S; Yatsuhashi H; Hamada H; Yano K; Matsumoto T; Daikoku M; Arisawa K; Ishibashi H; Koga M; Sata M; Yano M
Cancer; 2003 Dec; 98(12):2671-7. PubMed ID: 14669288
[TBL] [Abstract][Full Text] [Related]
7. Des-gamma-carboxy prothrombin (DCP) ratio is a useful prognostic tumor marker for single nodule hepatocellular carcinoma (HCC).
Murakami N; Tamano M; Yoneda M; Sugaya H; Hiraishi H
Hepatogastroenterology; 2008; 55(81):197-201. PubMed ID: 18507106
[TBL] [Abstract][Full Text] [Related]
8. Identification and purification of vitamin K-dependent proteins and peptides with monoclonal antibodies specific for gamma -carboxyglutamyl (Gla) residues.
Brown MA; Stenberg LM; Persson U; Stenflo J
J Biol Chem; 2000 Jun; 275(26):19795-802. PubMed ID: 10779512
[TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic Reduction Assay on Des-Gamma-Carboxy Prothrombin for Screening of Hepatocellular Carcinoma.
Chieh JJ; Huang KW; Chuang CP; Wei WC; Dong JJ; Lee YY
IEEE Trans Biomed Eng; 2016 Aug; 63(8):1681-6. PubMed ID: 26415145
[TBL] [Abstract][Full Text] [Related]
10. Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma.
Sugimoto H; Takeda S; Inoue S; Kaneko T; Watanabe K; Nakao A
Liver Int; 2003 Feb; 23(1):38-44. PubMed ID: 12640726
[TBL] [Abstract][Full Text] [Related]
11. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
[TBL] [Abstract][Full Text] [Related]
12. Des-gamma-carboxy prothrombin identified by P-11 and P-16 antibodies reflects prognosis for patients with hepatocellular carcinoma.
Takeji S; Hirooka M; Koizumi Y; Tokumoto Y; Abe M; Ikeda Y; Nadano S; Hiasa Y; Onji M
J Gastroenterol Hepatol; 2013 Apr; 28(4):671-7. PubMed ID: 23215762
[TBL] [Abstract][Full Text] [Related]
13. Des-γ-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.
Sumi A; Akiba J; Ogasawara S; Nakayama M; Nomura Y; Yasumoto M; Sanada S; Nakashima O; Abe T; Yano H
PLoS One; 2015; 10(3):e0118452. PubMed ID: 25739032
[TBL] [Abstract][Full Text] [Related]
14. Distribution of gamma-carboxyglutamic acid residues in partially carboxylated human prothrombins.
Borowski M; Furie BC; Furie B
J Biol Chem; 1986 Feb; 261(4):1624-8. PubMed ID: 3944102
[TBL] [Abstract][Full Text] [Related]
15. A variant of des-gamma-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma.
Ohhira M; Saito H; Suzuki Y; Naraki T; Sakurai S; Ohtake T; Suzuki M; Ohhira M; Fujimoto And Y; Kohgo Y
Alcohol Clin Exp Res; 2001 Jun; 25(6 Suppl):46S-50S. PubMed ID: 11410741
[TBL] [Abstract][Full Text] [Related]
16. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
Yamagata H; Nakanishi T; Furukawa M; Okuda H; Obata H
J Gastroenterol Hepatol; 1995; 10(1):8-13. PubMed ID: 7620113
[TBL] [Abstract][Full Text] [Related]
17. Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma.
Tanaka T; Taniguchi T; Sannomiya K; Takenaka H; Tomonari T; Okamoto K; Kitamura S; Okahisa T; Tamaki K; Mikasa H; Suzuki S; Takayama T
J Gastroenterol Hepatol; 2013 Aug; 28(8):1348-55. PubMed ID: 23432345
[TBL] [Abstract][Full Text] [Related]
18. Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma.
Ohhira M; Ohtake T; Saito H; Ikuta K; Tanaka K; Tanabe H; Kawashima T; Fujimoto Y; Naraki T; Ono M; Kohgo Y
Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):67S-70S. PubMed ID: 10235282
[TBL] [Abstract][Full Text] [Related]
19. Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin.
Motohara K; Kuroki Y; Kan H; Endo F; Matsuda I
Pediatr Res; 1985 Apr; 19(4):354-7. PubMed ID: 4000762
[TBL] [Abstract][Full Text] [Related]
20. Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.
Okuda H; Obata H; Nakanishi T; Furukawa R; Hashimoto E
J Hepatol; 1987 Jun; 4(3):357-63. PubMed ID: 3036940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
